The following case topic will be presented at the Hematologic Malignancy Grand Rounds Conference on Friday, August 29, 2014 from 9:15 a.m. - 10:15 a.m. in M224 Markee Classroom, Second Floor, Green Zone, Duke South Clinic's Davison Building.
Title: “Putting the “I” in Frontline? Ibrutinib and Idelalisib in Upfront CLL Therapy”
By: Danielle Brander, MD
**SMS CODE FOR CREDIT WILL BE PROVIDED BY THE PRESENTER(S) **
The Duke University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
NO FOOD ALLOWED in M224 Davison Bldg
- 1.00 AMA PRA Category 1 Credit(s)™